Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report.
Giardini
C
C
Divisione di Ematologia, Centro Trapianto di Midollo Osseo, Osp. di Pesaro.
La Nasa
G
G
Contu
L
L
Galimberti
M
M
Polchi
P
P
Angelucci
E
E
Baronciani
D
D
Barbanti
I
I
Muretto
P
P
Lucarelli
G
G
D000293:Adolescent; D015913:Chelation Therapy; D003131:Combined Modality Therapy; D003676:Deferoxamine / Q000009:adverse effects / Q000627:therapeutic use*; D005293:Ferritins / Q000097:blood; D006432:Hemochromatosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007501:Iron / Q000032:analysis; D008099:Liver / Q000737:chemistry / Q000473:pathology; D008107:Liver Diseases / Q000188:drug therapy / Q000209:etiology; D008297:Male; D011184:Postoperative Period; D065227:Transfusion Reaction; D017086:beta-Thalassemia / Q000150:complications / Q000601:surgery* / Q000628:therapy
D005293:Ferritins; D007501:Iron; D003676:Deferoxamine